These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10468026)

  • 61. The effects of -blocking drugs on atrioventricular conduction and contractility.
    Fitzgerald JD; Wale J
    Cardiology; 1971; 56(1):338-43. PubMed ID: 4403201
    [No Abstract]   [Full Text] [Related]  

  • 62. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Beta-adrenoceptor antagonists and human sperm motility.
    Curtis-Prior PB; Gadd AL
    J Pharm Pharmacol; 1990 Mar; 42(3):220-2. PubMed ID: 1974626
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique.
    Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
    Biol Pharm Bull; 1999 Oct; 22(10):1089-93. PubMed ID: 10549861
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of systemic administrated beta-blockers on tear secretion.
    Singer L; Knobel B; Romem M
    Ann Ophthalmol; 1984 Aug; 16(8):728-9. PubMed ID: 6149719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.
    Whyte K; Jones CR; Howie CA; Deighton N; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1987; 32(3):237-43. PubMed ID: 2885202
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 68. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 69. Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer.
    Williams EM; Bagwell EE; Singh BN
    Cardiovasc Res; 1973 Mar; 7(2):226-40. PubMed ID: 4144352
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effects of four beta-blocking agents on some psychopharmacological tests in mice (author's transl)].
    Francès H; Puech AJ; Chermat R; Simon P
    Psychopharmacology (Berl); 1979 May; 63(1):43-8. PubMed ID: 38471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Arrhythmogenic effect of beta-adrenoceptor-blocking drugs in Purkinje fibres of guinea-pig hearts.
    Lemmens-Gruber R; Zilberszac A; Heistracher P
    Arch Int Pharmacodyn Ther; 1996; 331(1):46-58. PubMed ID: 8896710
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of inderal and trasicor on the function of external respiration in chronic coronary insufficiency].
    Liutoev GI; Ermilov LP
    Kardiologiia; 1973 Oct; 13(10):96-103. PubMed ID: 4150015
    [No Abstract]   [Full Text] [Related]  

  • 73. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032
    [No Abstract]   [Full Text] [Related]  

  • 74. Chronic effects assessment and plasma concentrations of the beta-blocker propranolol in fathead minnows (Pimephales promelas).
    Giltrow E; Eccles PD; Winter MJ; McCormack PJ; Rand-Weaver M; Hutchinson TH; Sumpter JP
    Aquat Toxicol; 2009 Nov; 95(3):195-202. PubMed ID: 19819565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
    Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM
    Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
    Lee VH; Yamamoto A; Kompella UB
    Crit Rev Ther Drug Carrier Syst; 1991; 8(2):91-192. PubMed ID: 1934087
    [No Abstract]   [Full Text] [Related]  

  • 77. The haemodynamic effects of ( )-propranolol, dexpropranolol, oxprenolol, practolol and sotalol in anaesthetised dogs.
    Fitzgerald JD; Wale JL; Austin M
    Eur J Pharmacol; 1972 Jan; 17(1):123-34. PubMed ID: 4401429
    [No Abstract]   [Full Text] [Related]  

  • 78. Evaluation of HO-1-u-1 cell line as an in vitro model for sublingual drug delivery involving passive diffusion--Initial validation studies.
    Wang Y; Zuo Z; Lee KK; Chow MS
    Int J Pharm; 2007 Apr; 334(1-2):27-34. PubMed ID: 17079100
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 80. Evaluation of -adrenergic blocking agents in presence of adrenergic tone.
    Elharrar V; Nadeau RA
    Can J Physiol Pharmacol; 1972 May; 50(5):381-8. PubMed ID: 4402699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.